New treatment for rare bone marrow condition.
D001374:Azacitidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000077209:Decitabine; D006801:Humans; D009190:Myelodysplastic Syndromes / Q000188:drug therapy* / Q000209:etiology; D009965:Orphan Drug Production; D014481:United States; D014486:United States Food and Drug Administration
D000077209:Decitabine; D001374:Azacitidine